CLINICAL_TRIALS
trial_result
· 2017-03-28
Clinical Trial Update: Study of Efficacy and Safety of CVAA489 in Hypertensive Patients [Phase 4]
Summary
This update presents the results of a Phase 4 trial evaluating the efficacy and safety of CVAA489 in adults with essential hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2017-03-28